Deucravacitinib in Plaque Psoriasis: Laboratory Parameters Through 4 Years of Treatment in the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials. J of Skin [Internet]. 2024 Nov. 18 [cited 2026 Apr. 20];8(6):s419. Available from: https://skin.dermsquared.com/skin/article/view/3086